All In MedTech

Device Trial Radar · NCT00180570

SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes

Scandinavian Atrial Lead Trial

Last checked: Nov 20, 2026Latest source record: Mar 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

SuspendedPivotal-lookingRandomized with 385 participants. This is a heuristic, not a regulatory label.

Status

Suspended

Enrollment

385

Actual

Start

Jan 1997

Primary completion

Not stated

Study completion Jan 2006

Sponsor

Lead sponsor
Guidant CorporationNot on our public-company list
Sponsor type
Industry
First posted
Sep 16, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomised Comparison with regards to complication rate and electrical measurements of atrial leads with different fixation mechnism

Conditions

  • Bradycardia

Interventions

  • FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary objective of this study is to compare repositioning rate due to threshold > 3.0 V @ 0.5 ms or P-wave < 0.8 mV between FineLine II Sterox 4480 and 4470, and between 4456 and 4470.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sahlgrenska Sjukhuset i Göteborg Sweden,

    Gothenburg, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.